1Alvarsson M,Sundkvist G,Lager I,et al.Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic controlin recently diagnosed type 2 diabetic patients[J].Diabetes Care,2003,26:2231-2237
1Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care, 2001,24 : 89-94.
2Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 1995,44: 1386-1391.
3Bruce DG, Chisholm DJ, Leonare H, et al. Physiological importance of deficiency in early prandial insulin secretion in non-in-sulin-dependent diabetes. Diabetes, 1988,37: 736-743.
4Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48: 99-105.
5Ilkova H, glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
6Walton C, Godsland IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab,1992,75: 170-175.
7Chan JL, Abrahamson MJ. Pharmacological management of type
8diabetes mellitus: rationale for rational use of insulin. Mayo Clin Proc2003 ;78: 459 - 467.2.De Witt DE, Dugdale DC. Using new insulin strategies in the outpatient treatment of diabetes: clinical applications. JAMA 2003;289: 2265 - 2269.
9De Witt DE, Hirsch IB. Outpatient insulin therapy in type 1 andtype 2 diabetes mellitus: scientific review. JAMA 2003, 289: 2254 -2264.
10Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation2004; 109:1497 - 1502.
3Ligthelm R J, Mouritzen U, Lynggaard H, Landin - Olsson M, Fox C et al. Biphase insulin aspart given thrice daily is as efficacious as a basal - bolus insulin regimen with four dily injections. Exp Clin Endocrinol Diabetes,2006,114:511 - 519.
4Chen JW, Lauritzen T, Bojesen A, Christiansen JS. Multiple meahime administration of biphasic insulin aspart 30 versus traditional basal - bolus human insulin treatment in patients with type 1 diabetes. Diabetes ,Obesity and Metabolisim ,2006,8:682 - 689.
5Lindholm A, Jacobsen LV. Clinical pharmacokinetics and pharmaco, dynamics of insulin aspart. Clin pharmacokinet,2001,40(9) :641 - 659.
6Ligthelm RJ,Mouritzen U,Lynggaard H,Landin-Ol-sson M,Fox C,et al.Biphase insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four dily injections[J].Exp Clin Endocrinol Diabetes,2006,114:511-519.
